Bellamy's Australia (ASX:BAL) and Wattle Health Australia (ASX:WHA) are both consumer defensive companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.
Analyst Ratings
This is a summary of current recommendations and price targets for Bellamy's Australia and Wattle Health Australia, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Bellamy's Australia | 0 | 0 | 0 | 0 | N/A |
Wattle Health Australia | 0 | 0 | 0 | 0 | N/A |
Earnings and Valuation
This table compares Bellamy's Australia and Wattle Health Australia's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Bellamy's Australia | N/A | N/A | N/A | N/A | N/A |
Wattle Health Australia | $1.19 million | 0.00 | $-53,741,215.14 | A($0.23) | N/A |
Bellamy's Australia has higher earnings, but lower revenue than Wattle Health Australia.
Profitability
This table compares Bellamy's Australia and Wattle Health Australia's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Bellamy's Australia | N/A | N/A | N/A |
Wattle Health Australia | N/A | N/A | N/A |
Summary
Wattle Health Australia beats Bellamy's Australia on 1 of the 1 factors compared between the two stocks.